Tower Research Capital LLC (Trc) Amphastar Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,145 shares of AMPH stock, worth $36,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,145
Previous 797
43.66%
Holding current value
$36,056
Previous $38,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AMPH
# of Institutions
274Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$85.5 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$58 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$50.3 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$43.3 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.54B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...